Year of Expanding into Circulating Biomarkers.

Q3 Medicine

Journal of Circulating Biomarkers Pub Date : 2015-01-29 eCollection Date: 2015-01-01 DOI:10.5772/60126

Shidong Jia, Winston Patrick Kuo

引用次数: 3

Abstract

This editorial article summarizes the achievements and current challenges for the Journal of Circulating Biomarkers (JCB) regarding a more strategic approach to branding and attracting a high quality variety of articles. More emphasis is placed on fostering engagement with academic and industry sources operating at the cutting-edge of translational technologies applied to the field of circulating biomarkers (interface between extracellular vesicles including exosomes and microvesicles, circulating tumour cells, cell-free circulating DNA and circulating protein markers) and with those in the investment arena seeking and providing private funding for this area of research.

查看原文本刊更多论文

扩展到循环生物标志物的一年。

这篇社论文章总结了《循环生物标志物杂志》(JCB)在品牌推广和吸引高质量文章方面所取得的成就和当前面临的挑战。更多的重点放在促进与应用于循环生物标志物(包括外泌体和微囊泡在内的细胞外囊泡之间的界面，循环肿瘤细胞，无细胞循环DNA和循环蛋白质标记)领域翻译技术前沿的学术和行业资源的合作，以及与投资领域寻求和提供该领域研究私人资金的人士的合作。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Journal of Circulating Biomarkers Medicine-Biochemistry (medical)

CiteScore

3.20

自引率

0.00%

发文量

审稿时长

8 weeks

期刊介绍： Journal of Circulating Biomarkers is an international, peer-reviewed, open access scientific journal focusing on all aspects of the rapidly growing field of circulating blood-based biomarkers and diagnostics using circulating protein and lipid markers, circulating tumor cells (CTC), circulating cell-free DNA (cfDNA) and extracellular vesicles, including exosomes, microvesicles, microparticles, ectosomes and apoptotic bodies. The journal publishes high-impact articles that deal with all fields related to circulating biomarkers and diagnostics, ranging from basic science to translational and clinical applications. Papers from a wide variety of disciplines are welcome; interdisciplinary studies are especially suitable for this journal. Included within the scope are a broad array of specialties including (but not limited to) cancer, immunology, neurology, metabolic diseases, cardiovascular medicine, regenerative medicine, nosology, physiology, pathology, technological applications in diagnostics, therapeutics, vaccine, drug delivery, regenerative medicine, drug development and clinical trials. The journal also hosts reviews, perspectives and news on specific topics.